Previous study has illustrated that Clusterin exhibited protective effects in NAFLD and western diet-induced obesity through activating AMPK and Nrf2 (Park et al. 2020). This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.